Zio ECG Utilization Software (ZEUS) System vs Cardiologs Holter Platform

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Philips France Commercial

AI Verdict

Both the Zio ECG Utilization Software (ZEUS) System and the Cardiologs Holter Platform are AI-powered, cloud-based solutions designed to assist healthcare professionals in diagnosing cardiac arrhythmias. While ZEUS focuses on analyzing continuous ECG data from iRhythm's proprietary Zio wearable monitors, the Cardiologs platform offers vendor-neutral analysis for traditional Holter ECG devices. This distinction in data source and monitoring duration makes them direct competitors for arrhythmia detection, with each offering specific advantages based on the preferred monitoring approach.

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if your practice requires a comprehensive, long-term continuous cardiac monitoring solution integrated with iRhythm's proprietary Zio wearable biosensors. This system is ideal for leveraging deep-learned algorithms to analyze extended ECG data (up to 14 days) for thorough arrhythmia detection and management.

View Zio ECG Utilization Software (ZEUS) System →

Choose Cardiologs Holter Platform if…

Choose the Cardiologs Holter Platform if your clinic needs a highly efficient, vendor-neutral AI-powered solution for analyzing traditional Holter ECG data from a variety of devices. This platform is best suited for practices aiming to significantly reduce Holter analysis time and streamline diagnostics across their existing Holter equipment, with a flexible pay-per-ECG pricing model.

View Cardiologs Holter Platform →

When choosing between the Zio ECG Utilization Software (ZEUS) System and the Cardiologs Holter Platform, physicians should consider their primary use case and existing infrastructure. The ZEUS System, from iRhythm Technologies, excels in long-term continuous ECG monitoring, leveraging its proprietary Zio wearable biosensors for up to 14 days of data analysis. It is best suited for practices focused on extended, ambulatory cardiac rhythm assessment and those seeking a comprehensive, integrated solution that includes both the monitoring device and the AI-powered analysis platform. The system provides detailed end-of-wear reports and integrates with EHRs via HL7.

In contrast, the Philips Cardiologs Holter Platform is a vendor-neutral, cloud-based solution designed for fast and accurate analysis of traditional Holter ECG data. It is ideal for practices that utilize various Holter devices and prioritize efficiency in processing existing Holter studies, boasting a reported 42% reduction in analysis time. This platform is particularly beneficial for cardiologists who need to quickly detect and classify over 20 types of arrhythmias from diverse Holter inputs.

The key practical difference lies in their approach to data acquisition: ZEUS is a closed system optimized for its own Zio monitors, offering extended wear times, while Cardiologs is an open platform compatible with multiple Holter devices, focusing on rapid analysis of shorter-duration recordings. Physicians prioritizing long-term, integrated monitoring with a dedicated device should lean towards ZEUS. Those needing a flexible, efficient AI analysis tool for various Holter devices and shorter monitoring periods would find the Cardiologs platform more suitable.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio ECG Utilization Software (ZEUS) System Cardiologs Holter Platform
Pricing Contact for pricing Contact sales
Deployment Cloud-based (AWS EC2 platform) Cloud-based (SaaS)
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiologs Holter Platform

Tool B explicitly highlights a significant reduction in Holter analysis time (approximately 42%) and the generation of easy-to-read, automatically enriched reports, directly improving workflow efficiency and user experience. While Tool A offers a mobile application, Tool B's focus on streamlining the core analysis task provides a more tangible usability advantage.

Clinical Value

Zio ECG Utilization Software (ZEUS) System

Tool A offers continuous ECG data analysis for up to 14 days, leveraging its proprietary Zio wearable biosensors. This extended monitoring duration significantly increases the likelihood of capturing intermittent arrhythmias, providing a higher diagnostic yield compared to traditional shorter-duration Holter monitoring.

Pricing & Value

Cardiologs Holter Platform

Tool B offers a more transparent pricing model by stating a 'Pay per ECG' structure, which allows potential customers to better understand and predict costs based on usage volume. In contrast, Tool A provides no public details regarding its pricing model, making it harder to assess value without direct engagement.

Enterprise Readiness

Cardiologs Holter Platform

Both tools demonstrate strong enterprise readiness with cloud deployment, HIPAA compliance, FDA clearance, and EHR integration. However, Tool B's explicit mention of secure data hosting on ISO/IEC 27001 certified AWS servers provides an additional, robust layer of assurance regarding information security management, which is highly valued in enterprise environments.

Innovation

Zio ECG Utilization Software (ZEUS) System

Tool A demonstrates greater innovation by integrating proprietary wearable biosensors for continuous ECG data analysis up to 14 days, moving beyond traditional intermittent monitoring. This integrated ecosystem and extended monitoring capability represent a more significant advancement in the methodology of cardiac diagnostics compared to optimizing existing Holter workflows.

Support & Docs

Tie

Both companies, iRhythm Technologies and Philips, indicate offering standard customer and technical support for healthcare professionals through their respective websites. However, the provided structured facts and public web searches do not offer sufficient detailed information on the depth, breadth, or specific features of their documentation or support services to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio ECG Utilization Software (ZEUS) System Cardiologs Holter Platform
Name Zio ECG Utilization Software (ZEUS) System Cardiologs Holter Platform
Company iRhythm Technologies Philips France Commercial
Key Features AI algorithm for arrhythmia detection and classification, Continuous ECG data analysis (up to 14 days), Cloud-based data analytics (AWS EC2 platform), Proprietary deep-learned algorithms for enhanced diagnostic accuracy, ZioSuite web portal and mobile application for healthcare professionals, Comprehensive end-of-wear reports for physician review, Integration with Zio wearable biosensors (Zio monitor, Zio Watch), HL7-based EHR integration AI-powered deep learning technology for ECG analysis, Cloud-based platform for anytime, anywhere access, Vendor-neutral compatibility with multiple Holter devices, Reduces Holter analysis time by approximately 42%, Detects over 20 types of arrhythmias, Integration with Electronic Medical Record (EMR) systems (Philips IntelliBridge Enterprise), Secure data hosting on ISO/IEC 27001 certified AWS servers, Generates easy-to-read, automatically enriched reports
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and Cardiologs Holter Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio ECG Utilization Software (ZEUS) System integrates specifically with iRhythm's Zio wearable biosensors, such as the Zio monitor and Zio Watch. In contrast, the Cardiologs Holter Platform offers vendor-neutral compatibility with multiple Holter devices.
The ZEUS System analyzes continuous ECG data from wearable Zio monitors for up to 14 days. The Cardiologs Holter Platform is designed for fast and accurate analysis of Holter ECG data.
The Cardiologs Holter Platform is stated to detect over 20 types of arrhythmias. The ZEUS System utilizes an AI algorithm for arrhythmia detection and classification, providing comprehensive end-of-wear reports.
The Zio ECG Utilization Software (ZEUS) System offers HL7-based EHR integration. The Cardiologs Holter Platform integrates with Electronic Medical Record (EMR) systems, specifically mentioning Philips IntelliBridge Enterprise.
The Zio ECG Utilization Software (ZEUS) System is designed for Cardiology, Family Medicine, and Internal Medicine. The Cardiologs Holter Platform is primarily focused on Cardiology.
The Cardiologs Holter Platform explicitly states that it reduces Holter analysis time by approximately 42%. The Zio ECG Utilization Software (ZEUS) System utilizes AI for analysis but does not provide a specific quantitative claim regarding time reduction.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.